Loading...
Loading...
Among the 8 tracked institutional investors we monitor, ABOS (ACUMEN PHARMACEUTICALS INC) is held with a combined value of $9.86M across 4,354,168 shares. The largest holder is VANGUARD GROUP INC with a position worth $3.49M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 5 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$9.86M
Total Shares Held
4,354,168
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $3.49M | 0.00% | New |
| 2 | FMR LLC | $2.73M | 0.00% | -42.9% |
| 3 | MILLENNIUM MANAGEMENT LLC | $1.56M | 0.00% | +12.9% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $1.12M | 0.00% | +12.0% |
| 5 | BlackRock, Inc. | $420.85K | 0.00% | +5.2% |
| 6 | STATE STREET CORP | $358.08K | 0.00% | +51.5% |
| 7 | Point72 Asset Management, L.P. | $159.00K | 0.00% | +85.3% |
| 8 | CITADEL ADVISORS LLC | $28.32K | 0.00% | -96.8% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of ABOS with a position worth $3.49M, representing 0.00% of their portfolio. In total, 8 institutional investors hold ABOS with a combined value of $9.86M.
In the most recent quarter, 1 fund opened a new position in ABOS. Additionally, 5 increased their holdings and 2 reduced their positions.
Institutional investors hold $9.86M worth of ABOS stock across 8 positions. The largest institutional holder is VANGUARD GROUP INC with $3.49M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ABOS, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ABOS positions.